Ninian N. Lang

6.6k total citations · 1 hit paper
87 papers, 2.1k citations indexed

About

Ninian N. Lang is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ninian N. Lang has authored 87 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Cardiology and Cardiovascular Medicine, 17 papers in Oncology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ninian N. Lang's work include Chemotherapy-induced cardiotoxicity and mitigation (23 papers), Heart Failure Treatment and Management (14 papers) and Cardiovascular Function and Risk Factors (12 papers). Ninian N. Lang is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (23 papers), Heart Failure Treatment and Management (14 papers) and Cardiovascular Function and Risk Factors (12 papers). Ninian N. Lang collaborates with scholars based in United Kingdom, United States and Canada. Ninian N. Lang's co-authors include Rhian M. Touyz, David E. Newby, Alan C. Cameron, Mark C. Petrie, Stephen J.H. Dobbin, Sowmya Venkatasubramanian, John J.V. McMurray, Donald Liu, Richard Weller and Martin Feelisch and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Ninian N. Lang

77 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction

2021 155 citations Rhian M. Touyz, Clare Murphy et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ninian N. Lang United Kingdom	26	922	441	377	306	287	87	2.1k
Martino Deidda Italy	26	972 1.1×	355 0.8×	280 0.7×	254 0.8×	194 0.7×	86	1.9k
Erik Lipšic Netherlands	24	1.1k 1.2×	589 1.3×	410 1.1×	188 0.6×	234 0.8×	103	2.9k
Christian Cadeddu Dessalvi Italy	27	1.4k 1.5×	347 0.8×	477 1.3×	278 0.9×	149 0.5×	106	2.1k
Gabriela M. Kuster Switzerland	24	989 1.1×	723 1.6×	205 0.5×	190 0.6×	166 0.6×	58	2.4k
Wouter C. Meijers Netherlands	31	1.9k 2.0×	723 1.6×	581 1.5×	362 1.2×	203 0.7×	80	3.5k
Namık Kemal Eryol Türkiye	16	1.1k 1.2×	366 0.8×	390 1.0×	344 1.1×	94 0.3×	49	1.8k
Izuru Masuda Japan	22	1.1k 1.2×	422 1.0×	218 0.6×	249 0.8×	167 0.6×	77	1.8k
Annette Oeser United States	30	766 0.8×	660 1.5×	266 0.7×	195 0.6×	156 0.5×	58	3.5k
Aaron L. Sverdlov Australia	26	1.0k 1.1×	411 0.9×	107 0.3×	352 1.2×	465 1.6×	103	2.0k
Matthew C. Hyman United States	20	1.1k 1.1×	564 1.3×	244 0.6×	230 0.8×	258 0.9×	76	2.7k

Countries citing papers authored by Ninian N. Lang

Since Specialization

Citations

This map shows the geographic impact of Ninian N. Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ninian N. Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ninian N. Lang more than expected).

Fields of papers citing papers by Ninian N. Lang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ninian N. Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ninian N. Lang. The network helps show where Ninian N. Lang may publish in the future.

Co-authorship network of co-authors of Ninian N. Lang

This figure shows the co-authorship network connecting the top 25 collaborators of Ninian N. Lang. A scholar is included among the top collaborators of Ninian N. Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ninian N. Lang. Ninian N. Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Kuan Ken, Olga Oikonomidou, Peter Hall, et al.. (2025). Anthracycline Dose, Myocardial Injury, and Change in Left Ventricular Function in the Cardiac CARE Trial. JACC CardioOncology. 7(6). 725–735.

Manisty, Charlotte & Ninian N. Lang. (2025). Cure sometimes, treat often, comfort always: reflections on the feasibility and timing of trials in the palliative setting. European Heart Journal. 47(9). 1047–1049.

Sullivan, Michael, Nicole De La Mata, Angela C Webster, et al.. (2024). The impact of VEGF signalling pathway inhibitors and/or immune checkpoint inhibitors on kidney function over time: a single centre retrospective analysis. SHILAP Revista de lepidopterología. 2(1). 57–57.

Leong, Darryl P., Sarah Waliany, Husam Abdel‐Qadir, et al.. (2024). Cardiovascular Considerations During Cancer Therapy. JACC CardioOncology. 6(6). 815–834. 7 indexed citations

Burton, Francis L., et al.. (2024). Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Preclinical Cardiotoxicity Screening in Cardio-Oncology. JACC CardioOncology. 6(5). 678–683. 4 indexed citations

Henderson, Alasdair, J. Andrew McClure, Balaji Venugopal, et al.. (2024). Arterial effects of anthracycline: structural and inflammatory assessments in non-human primates and lymphoma patients. Clinical Science. 139(1). 29–41.

Lee, Matthew M.Y., Mark C. Petrie, Ninian N. Lang, et al.. (2024). 137 Efficacy of intravenous ferric derisomaltose in hospitalised and outpatient settings: insights from ironman trial. ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam). A143–A145. 1 indexed citations

Mooney, Leanne, Colette E. Jackson, Carly Adamson, et al.. (2023). Adverse Outcomes Associated With Interleukin-6 in Patients Recently Hospitalized for Heart Failure With Preserved Ejection Fraction. Circulation Heart Failure. 16(4). 33 indexed citations

Dobbin, Stephen J.H., Li Shen, Mark C. Petrie, et al.. (2023). Characteristics and Outcomes of Patients with a History of Cancer Recruited to Heart Failure Trials. European Journal of Heart Failure. 25(4). 488–496. 8 indexed citations

10.

Kalra, Paul R., John G.F. Cleland, Mark C. Petrie, et al.. (2022). Rationale and design of a randomised trial of intravenous iron in patients with heart failure. Heart. 108(24). 1979–1985. 6 indexed citations

11.

Ehteshami‐Afshar, Solmaz, Leanne Mooney, Pooja Dewan, et al.. (2021). Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM‐HF. Journal of the American Heart Association. 10(4). e019238–e019238. 27 indexed citations

12.

Rossitto, Giacomo, Sheon Mary, Karla B Neves, et al.. (2020). Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction. Journal of the American College of Cardiology. 76(24). 2817–2829. 50 indexed citations

13.

Ahmad, Faheem, Mark C. Petrie, John J.V. McMurray, & Ninian N. Lang. (2019). Personalized Medicine and Hospitalization for Heart Failure: If We Understand it, We May be Successful in Treating It. European Journal of Heart Failure. 21(6). 699–702. 5 indexed citations

14.

Adamson, Philip D, Peter Hall, Ninian N. Lang, et al.. (2018). DYNAMIC CHANGES IN HIGH SENSITIVITY CARDIAC TROPONIN I IN RESPONSE TO ANTHRACYCLINE-BASED CHEMOTHERAPY: A PILOT STUDY FOR THE CARDIAC CARE TRIAL. Journal of the American College of Cardiology. 71(11). A701–A701. 1 indexed citations

15.

Cameron, Alan C., Ninian N. Lang, & Rhian M. Touyz. (2016). Drug Treatment of Hypertension: Focus on Vascular Health. Drugs. 76(16). 1529–1550. 58 indexed citations

16.

Fernandez, Bernadette, et al.. (2013). UVA lowers blood pressure and vasodilates the systemic arterial vasculature by mobilisation of cutaneous nitric oxide stores. ePrints Soton (University of Southampton). 1 indexed citations

17.

Venkatasubramanian, Sowmya, et al.. (2013). EFFECT OF UROCORTIN 2 AND 3 ON FOREARM ARTERIAL BLOOD FLOW IN PATIENTS WITH HEART FAILURE. Journal of the American College of Cardiology. 61(10). E647–E647. 1 indexed citations

18.

Tsang, Hilda, James Leiper, Laura Dowsett, et al.. (2013). Role of Asymmetric Methylarginine and Connexin 43 in the Regulation of Pulmonary Endothelial Function. Pulmonary Circulation. 3(3). 675–691. 21 indexed citations

19.

Alam, Shirjel, Jennifer Richards, Anoop Shah, et al.. (2013). NANOPARTICLE ENHANCED MRI: A NOVEL METHOD OF INVESTIGATING MYOCARDIAL INFLAMMATION. Journal of the American College of Cardiology. 61(10). E1072–E1072. 1 indexed citations

20.

Guðmundsdóttir, Ingibjörg Jóna, Ninian N. Lang, Nicholas A. Boon, et al.. (2008). Role of the Endothelium in the Vascular Effects of the Thrombin Receptor (Protease-Activated Receptor Type 1) in Humans. Journal of the American College of Cardiology. 51(18). 1749–1756. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact